Question stringlengths 37 217 | Answer stringlengths 1 1k | Evidence Text sequencelengths 1 3 | Company Name stringclasses 9
values | Ticker stringclasses 9
values | Filing year float64 2.02k 2.02k | Filing date stringclasses 9
values | CIK float64 80.4k 1.61M | GICS_Sector stringclasses 5
values | URL_HTML stringclasses 9
values | q-id int64 250 2.16k | corpus-id sequencelengths 1 3 | retrieved-text sequencelengths 84 100 | retrieved-id sequencelengths 84 100 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
What proportion of total net sales did Medtronic generate from emerging markets during FY 2023? | Net sales from emerging markets made up 17.4% of the total net sales during FY 2023. | [
"Segment and Market Geography\n The charts below illustrate the percent of net sales by market geography for fiscal years 2023 and 2022:\n The table below includes net sales by market geography for each of our segments for fiscal years 2023 and 2022:\n U.S. Non-U.S. Developed Markets Emerging Markets\n (in millions... | Medtronic plc | MDT | 2,023 | 2023-06-22 | 1,613,103 | Healthcare | https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-20230428.htm | 250 | [
7965,
7919
] | [
"Ticker: MDT; CIK: 0001613103; Filing Date: 20230428; Filing Year: April 28, 2023; Company Name: Medtronic plc\n\nSub-section: Sales and Distribution\n\nWe sell our medical devices and therapies through a combination of direct sales representatives and independent distributors globally. Additionally, a portion of t... | [
7851,
7919,
7992,
8085,
7920,
7918,
7991,
7849,
7846,
7821,
7876,
7924,
7906,
7976,
7856,
7916,
7841,
7938,
7868,
8045,
7956,
8010,
8023,
8026,
8083,
7914,
7897,
7869,
7965,
8081,
7847,
7826,
7820,
7824,
7845,
8012,
7936,
7940,
8090,
7939... |
"By what percentage did the net sales of Medtronic derived from United States change between FY 2022(...TRUNCATED) | "Net sales of Medtronic derived from the United States market increased by a meager 1.5% from FY 202(...TRUNCATED) | ["Medtronic plc\n Notes to Consolidated Financial Statements (Continued)\n Geographic Information\n (...TRUNCATED) | Medtronic plc | MDT | 2,023 | 2023-06-22 | 1,613,103 | Healthcare | https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-20230428.htm | 251 | [
8085
] | ["Ticker: MDT; CIK: 0001613103; Filing Date: 20230428; Filing Year: April 28, 2023; Company Name: M(...TRUNCATED) | [7919,7992,8085,7918,7916,7851,7991,8045,7920,8081,8053,7965,8026,7924,7914,7976,7856,7812,7878,7842(...TRUNCATED) |
What was the Non-GAAP net income margin of Medtronic during FY 2023? | Medtronic had a non-GAAP net income margin of 22.6% during FY 2023. | ["GAAP to Non-GAAP Reconciliations\n The tables below present reconciliations of our Non-GAAP financ(...TRUNCATED) | Medtronic plc | MDT | 2,023 | 2023-06-22 | 1,613,103 | Healthcare | https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-20230428.htm | 252 | [
7914,
7965
] | ["Ticker: MDT; CIK: 0001613103; Filing Date: 20230428; Filing Year: April 28, 2023; Company Name: M(...TRUNCATED) | [7914,7917,7965,7967,8045,7916,7934,8083,7992,7821,7919,7998,7912,7915,8026,8085,7976,8012,7906,7999(...TRUNCATED) |
What was the 3-year CAGR of Medtronic from FY 2021 to FY 2023? | The 3-year CAGR of Medtronic was 1.2% from FY 2021 to FY 2023. | ["Medtronic plc\n Consolidated Statements of Income\n Fiscal Year\n (in millions, except per share d(...TRUNCATED) | Medtronic plc | MDT | 2,023 | 2023-06-22 | 1,613,103 | Healthcare | https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-20230428.htm | 253 | [
7965
] | ["Ticker: MDT; CIK: 0001613103; Filing Date: 20230428; Filing Year: April 28, 2023; Company Name: M(...TRUNCATED) | [8037,7992,8010,7919,7991,8039,7938,7824,8079,7913,7936,7813,7906,7910,7902,8083,7918,7916,7924,7845(...TRUNCATED) |
"What proportion of Medtronic's net sales were derived from the neuroscience busines segment during (...TRUNCATED) | "28.7% of total net sales of Medtronic were derived from the neuroscience business segment during FY(...TRUNCATED) | ["NET SALES\n Segment and Division\n The charts below illustrate the percent of net sales by segment(...TRUNCATED) | Medtronic plc | MDT | 2,023 | 2023-06-22 | 1,613,103 | Healthcare | https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-20230428.htm | 254 | [
7918
] | ["Ticker: MDT; CIK: 0001613103; Filing Date: 20230428; Filing Year: April 28, 2023; Company Name: M(...TRUNCATED) | [7918,7919,7926,7991,8081,7992,8083,7835,8084,8085,8032,7924,7851,7916,7927,8003,8012,8010,7920,7914(...TRUNCATED) |
"What was Medtronic's YoY percentage change in the net sales from the cardiovascular segment during (...TRUNCATED) | Net sales from the cardiovascular segment of Medtronic increased by only 1% YoY during FY 2023. | ["NET SALES\n Segment and Division\n The charts below illustrate the percent of net sales by segment(...TRUNCATED) | Medtronic plc | MDT | 2,023 | 2023-06-22 | 1,613,103 | Healthcare | https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-20230428.htm | 255 | [
7918
] | ["Ticker: MDT; CIK: 0001613103; Filing Date: 20230428; Filing Year: April 28, 2023; Company Name: M(...TRUNCATED) | [7918,7919,7991,7992,8081,7827,7921,7924,7920,8084,8083,8006,8085,7851,7922,7916,8032,7829,7976,7906(...TRUNCATED) |
What was the gross profit of Medtronic for the FY 2023? | Medtronic generated a gross profit of $ 20,508 million in FY 2023. | ["Medtronic plc\n Consolidated Statements of Income\n Fiscal Year\n (in millions, except per share d(...TRUNCATED) | Medtronic plc | MDT | 2,023 | 2023-06-22 | 1,613,103 | Healthcare | https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-20230428.htm | 256 | [
7965
] | ["Ticker: MDT; CIK: 0001613103; Filing Date: 20230428; Filing Year: April 28, 2023; Company Name: M(...TRUNCATED) | [8083,7938,7821,7965,7992,7998,8079,7919,8039,7906,7991,7993,7913,8010,7824,7936,8084,8012,7914,7970(...TRUNCATED) |
Did Medtronic show an improvement in its gross profit margins in FY 2023 as compared to FY 2022? | No, the gross profit margin of Medtronic decreased from 68.0% in FY 2022 to 65.7% in FY 2023. | ["Medtronic plc\n Consolidated Statements of Income\n Fiscal Year\n (in millions, except per share d(...TRUNCATED) | Medtronic plc | MDT | 2,023 | 2023-06-22 | 1,613,103 | Healthcare | https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-20230428.htm | 257 | [
7965
] | ["Ticker: MDT; CIK: 0001613103; Filing Date: 20230428; Filing Year: April 28, 2023; Company Name: M(...TRUNCATED) | [7965,7993,7992,7913,7914,7919,7899,7896,7995,8026,7906,7824,7976,8083,7980,8079,7878,7932,7911,7991(...TRUNCATED) |
The research and development expense of Medtronic was what percentage of net sales during FY 2023? | The research and development expense of Medtronic is 8.6% of total net sales as of FY 2023. | ["Medtronic plc\n Consolidated Statements of Income\n Fiscal Year\n (in millions, except per share d(...TRUNCATED) | Medtronic plc | MDT | 2,023 | 2023-06-22 | 1,613,103 | Healthcare | https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-20230428.htm | 258 | [
7965
] | ["Ticker: MDT; CIK: 0001613103; Filing Date: 20230428; Filing Year: April 28, 2023; Company Name: M(...TRUNCATED) | [7849,7929,8034,7918,8083,8000,7965,7919,7992,7991,7924,8084,8085,7916,7851,8035,8081,7914,7976,7915(...TRUNCATED) |
"Was there any significant change in Medtronic's selling, general and administrative (SG&A) expense (...TRUNCATED) | "No, Medtronic did not witness any significant change in its selling, general and administrative exp(...TRUNCATED) | ["Medtronic plc\n Consolidated Statements of Income\n Fiscal Year\n (in millions, except per share d(...TRUNCATED) | Medtronic plc | MDT | 2,023 | 2023-06-22 | 1,613,103 | Healthcare | https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/mdt-20230428.htm | 259 | [
7965
] | ["Ticker: MDT; CIK: 0001613103; Filing Date: 20230428; Filing Year: April 28, 2023; Company Name: M(...TRUNCATED) | [7993,7906,7929,8089,7914,8083,7913,7937,7973,7990,8006,7992,8084,7932,8035,7919,7931,7896,7878,8026(...TRUNCATED) |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 5